Centessa Pharmaceuticals (CNTA)
NASDAQ: CNTA
· Real-Time Price · USD
12.97
0.20 (1.57%)
At close: May 28, 2025, 3:59 PM
12.95
-0.15%
After-hours: May 28, 2025, 06:08 PM EDT
1.57% (1D)
| Bid | 11.65 |
| Market Cap | 1.73B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -223.87M |
| EPS (ttm) | -1.88 |
| PE Ratio (ttm) | -6.9 |
| Forward PE | -8.7 |
| Analyst | Buy |
| Ask | 13.85 |
| Volume | 435,635 |
| Avg. Volume (20D) | 926,428 |
| Open | 13.23 |
| Previous Close | 12.77 |
| Day's Range | 12.73 - 13.12 |
| 52-Week Range | 7.75 - 19.09 |
| Beta | 1.54 |
About CNTA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CNTA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CNTA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-8.03%
Centessa Pharmaceuticals shares are trading lower ...
Unlock content with
Pro Subscription
8 months ago
+12.52%
Centessa Pharmaceuticals shares are trading higher. The company announced it priced a $225 million public offering of 15,254,237 American Depositary Shares at $14.75 per ADS
5 months ago · seekingalpha.com
Centessa: Shift In Focus With ORX750 Development Continues To Pay OffCentessa Pharmaceuticals shelved its SerpinPC candidate, which was being used to treat patients with Hemophilia B; Established net savings of $200 million because of this move. Positive interim and fi...